Pyoderma gangrenosum: A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions

Medicine

Volumn 79, Issue 1, 2000, Pages 37-46

  Bennett, Michelle L ^a   Jackson, J Mark ^b   Jorizzo, Joseph L ^a   Fleischer Jr , Alan B ^a   White, Wain L ^a   Callen, Jeffrey P ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CLOFAZIMINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISONE;

ADOLESCENT; ADULT; AGED; ALGORITHM; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DEBRIDEMENT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; REMISSION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PYODERMA GANGRENOSUM; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0033971605     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-200001000-00004     Document Type: Article

References (78)

1. Ackerman AB. Histologic diagnosis of inflammatory skin diseases: An algorithmic method based on pattern analysis. 2nd ed. Baltimore: Williams & Wilkins, pp 674-77, 1997.
2. August PJ, Wells GC. Pyoderma gangrenosum treated with azathioprine and prednisolone. Br J Dermatol 91(Suppl 10): 80-82, 1974.
3. Ayyala RS, Armstrong S. Corneal melting and scleromalacia perforans in a patient with pyoderma gangrenosum and acute myeloid leukemia. Ophthalmic Surg Lasers 29: 328-31, 1998.
4. Brennecke A. Peristomal pyoderma gangrenosum: Review and case study. Medsurg Nurs 5: 195-8, 217, 1996.
5. Brocq L. Nouvelle contribution a l'etude du phagedenisme geometrique. Ann Dermatol Syphiligr (Paris) 6: 1-39, 1916.
6. Brown RE, Lay L, Graham D. Bilateral pyoderma gangrenosum of the hand: Treatment with dapsone. J Hand Surg (Br) 18: 119-21, 1993.
7. Brown TS, Marshall GS, Callen JP. Cavitating pulmonary infiltrate in an adolescent with pyoderma gangrenosum: A rarely recognized extracutaneous manifestation of a neutrophilic dermatosis. J Am Acad Dermatol, 2000 (in press).
8. Brunsting LA, Goeckerman WH, O'Leary PA. Pyoderma (ecthyma) gangrenosum. Clinical and experimental observations in five cases occurring in adults. Arch Dermatol Syphilol 22: 655-80, 1930.
9. Bundino S, Zina AM. Pyoderma gangrenosum associated with selective hereditary IgA deficiency. Dermatologica 168: 230-32, 1984.
10. Burgess NA. Pyoderma gangrenosum with large circumferential perianal skin loss in a child. Br J Clin Pract 45: 223-24, 1991.
11. Burruss JB, Farmer ER, Callen JP. Chlorambucil is an effective corticosteroid-sparing agent for recalcitrant pyoderma gangrenosum. J Am Acad Dermatol 35: 720-24, 1996.
12. Byrne JPH, Hewitt M, Summerly R. Pyoderma gangrenosum associated with active chronic hepatitis: Report of two cases. Arch Dermatol 112: 1297-1301, 1976.
13. Cairns BA, Herbst CA, Sarton BR, Briggaman RA, Koruda MJ. Peristomal pyoderma gangrenosum and inflammatory bowel disease. Arch Surg 129: 769-72, 1994.
14. Callen JP. Pyoderma gangrenosum. Lancet 351: 581-85, 1998.
15. Callen JP. Pyoderma gangrenosum and related disorders. Med Clin North Am 73: 1247-61, 1989.
16. Callen JP, Case JD, Sager D. Chlorambucil - an effective corticosteroid-sparing therapy for pyoderma gangrenosum. J Am Acad Dermatol 21: 515-19, 1989.
17. Chow RKP, Ho VC. Treatment of pyoderma gangrenosum. J Am Acad Dermatol 34: 1047-60, 1996.
18. Clark HH, Cohen PR. Pyoderma gangrenosum in an HIV-infected patient. J Am Acad Dermatol 32: 912-14, 1995.
19. Dourmishev AL, Miteva I, Schwartz RA. Pyoderma gangrenosum in children. Pediatr Dermatol 58: 257-61, 1996.
20. Esnault P, Dompartin A, Moreau A, Caraes B, Leroy D. Recurring postoperative pyoderma gangrenosum. Int J Dermatol 34: 647-50, 1995.
21. Fedi MC, Quercetani R, Lotti T. Recalcitrant pyoderma gangrenosum responsive to cyclosporine. Int J Dermatol 32: 119, 1993.
22. Fradin MS, Ellis CN, Voorhees JJ. Management of patients and side effects during cyclosporine therapy for cutaneous disorders. J Am Acad Dermatol 23: 1265-75, 1990.
23. Freedman MD, Schocket AL, Chapel N, Gerber JG. Anaphylaxis after intravenous methylprednisolone administration. JAMA 245: 607-8, 1981.
24. Goldstein F, Krain R, Thornton JJ. Intralesional steroid therapy of pyoderma gangrenosum. J Clin Gastroenterol 7: 499-501, 1985.
25. Goulden V, Bond L, Highet AS. Pyoderma gangrenosum associated with paroxysmal nocturnal haemoglobinuria. Clin Exp Dermatol 19: 271-73, 1994.
26. Graham JA, Hansen KK, Rabinowitz LG, Esterly NB. Pyoderma gangrenosum in infants and children. Pediatr Dermatol 11: 10-17, 1994.
27. Green LK, Hebert AA, Jorizzo JL, Solomon AR. Pyoderma gangrenosum and chronic persistent hepatitis. J Am Acad Dermatol 13: 892-97, 1985.
28. Happel R, Schiffer H, Kovary PM. Ocular involvement in pyoderma gangrenosum [letter]. Arch Dermatol 113: 1612, 1977.
29. Harris AJ, Regan P, Burge S. Lesson of the week: Early diagnosis of pyoderma gangrenosum is important to prevent disfigurement. Br Med J 316: 52-53, 1998.
30. Hastier P, Caroli-Bosc FX, Bartel HR, Harris AG, Maes B, Arpurt JB, Taillan B, Bodock I, Dumas R, Delmont JP. Pyoderma gangrenosum with hepatopancreatic manifestations in a patient with rheumatoid arthritis. Digest Dis Sci 41: 594-97, 1996.
31. Hay CRM, Messenger AG, Cotton DWK, Brechen SS, Winfield DA. Atypical bullous pyoderma gangrenosum associated with myeloid malignancies. J Clin Pathol 40: 387-92, 1987.
32. Hayani A, Steuber CP, Mahoney DH, Levy ML. Pyoderma gangrenosum in childhood leukemia. Pediatr Dermatol 7: 296-98, 1990.
33. Haynes RC, Murad F. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of adrenocortical steroid biosynthesis. In: Gilman AG, Goodman LS, Gilman A, eds. The pharmacological basis of therapeutics. New York: MacMillan, pp 1466-96, 1980.
34. Hedayati, H, Zuzga JJ Jr, Farber DB. Rheumatoid arthritis, relapsing polychondritis, and pyoderma gangrenosum evolving into non-Hodgkin's lymphoma. J Am Osteopath Assoc 93: 240-42, 1993.
35. Hidano A, Watanabe K. Pyoderma gangrenosum and cardiovasculopathies, particularly Takayasu arteritis. Ann Dermatol Venereol 108: 13-21, 1981.
36. Ho VC, Zloty DM. Immunosuppressive agents in dermatology. Dermatol Clin 11:73-85, 1993.
37. Holt PJA, Davies MG, Saunders KC, Nuki G. Pyoderma gangrenosum: Clinical and laboratory findings in 15 patients with special reference to polyarthritis. Medicine (Baltimore) 59: 114-33, 1980.
38. Hughes JR, Smith E, Higgins EM, Barry H, du Vivier AW. Pyoderma gangrenosum in a patient with rheumatoid arthritis responding to treatment with cyclosporin A. Br J Rheum 33: 680-81, 1994.
39. Hurwitz RM, Haseman JH. The evolution of pyoderma gangrenosum: A clinicopathologic correlation. Am J Dermatopathol 15: 28-33, 1993.
40. Johnson ML, Grimwood RE. Leukocyte colony-stimulating factors: A reveiw of associated neutrophilic dermatoses and vasculidities. Arch Dermatol 130: 77-81, 1994.
41. Johnson RB, Lazarus GS. Pulse therapy: Therapeutic efficacy in the treatment of pyoderma gangrenosum. Arch Dermatol 118: 76-84, 1982.
42. Jorizzo JL, Solomon AR, Zanolli MD, Leshin B. Neutrophilic vascular reactions. J Am Acad Dermatol 19: 983-1005, 1988.
43. Kaplan B, Trau H, Sofer E, Feinstein A, Schewachmillet M. Treatment of pyoderma gangrenosum with clofazimine. Int J Dermatol 31: 591-93, 1992.
44. Keltz M, Lebwohl M, Bishop S. Peristomal pyoderma gangrenosum. J Am Acad Dermatol 27: 360-64, 1993.
45. Ko CB, Walton S, Wyatt EH. Pyoderma gangrenosum: Associations revisited. Int J Dermatol 31: 574-77, 1992.
46. Koester G, Tarnower A, Levisohn D, Burgdorf W. Bullous pyoderma gangrenosum. J Am Acad Dermatol 29: 875-78, 1993.
47. Lebbe C, Moulonguet-Michau I, Perrin P, Blanc F, Frija J, Civatte J. Steroid-responsive pyoderma gangrenosum with vulvar and pulmonary involvement. J Am Acad Dermatol 27: 623-25, 1922.
48. Lever WF, Schaumburg-Lever G. Systemic diseases with cutaneous manifestations. In: Histopathology of the skin. Philadelphia: JB Lippincott, 1990.
49. Martis WL, Ellis CN, Griffiths CEM, Lazarus GS. Treatment of pyoderma gangrenosum with cyclosporine. Arch Dermatol 128: 1060-64, 1992.
50. McCalmont CS, Leshin B, White WL, Greiss FC Jr, Jorizzo JL. Vulvar pyoderma gangrenosum. Int J Gynecol Obstet 35: 175-78, 1991.
51. McCulloch AJ, McMillan M, Jackson JD, Jarvis EH. Severe steroid responsive pneumonitis associated with pyoderma gangrenosum and ulcerative colitis. Thorax 40: 314-15, 1985.
52. McDougall AC, Horsfall WR, Hede JE, Chaplin AJ. Splenic infarction and tissue accumulation of crystals associated with the use of clofazimine (Lamprene; B663) in the treatment of pyoderma gangrenosum. BrJ Dermatol 102: 227-30, 1980.
53. Mensing H. Clofazimine in dermatitis ulcerosa (pyoderma gangrenosum): Open clinical trial. Dermatologica 177: 232-36, 1988.
54. Micali G, Cook B, Ronan S, Yadgir J, Solomon LM. Cephalic pyoderma gangrenosum (PG)-like lesions as a presenting sign of Wegener's granulomatosis. Int J Dermatol 33: 477-80, 1994.
55. Moschella SL. Pyoderma gangrenosum: A patient successfully treated with intralesional injections of steroid. Arch Dermatol 95: 121-3, 1967.
56. Perry HO, Brunsting LA. Pyoderma gangrenosum. A clinical study of nineteen cases. AMA Arch Dermatol 75: 380-86, 1957.
57. Perry HO, Winkelmann RK. Bullous pyoderma gangrenosum and leukemia. Arch Dermatol 106: 901-5, 1972.
58. Powell FC, Perry HO. Pyoderma gangrenosum in childhood. Arch Dermatol 120: 757-61, 1984.
59. Powell FC, Schroeter AL, Su WP, Perry HO. Pyoderma gangrenosum: a review of 86 patients. Q J Med 55: 173-86, 1985.
60. Prystowsky JH, Khan SN, Lazarus GS. Present status of pyoderma gangrenosum: Review of 21 cases. Arch Dermatol 125: 57-64, 1989.
61. Rand RP, Olerud JE, Verrier ED. Pyoderma gangrenosum after coronary artery bypass grafting. Ann Thorac Surg 55: 1016-18, 1993.
62. Rapini RP. Cytotoxic drugs in the treatment of skin disease. Int J Dermatol 30: 313-22, 1991.
63. Resnik BI, Rendon M, Kerdel FA. Successful treatment of aggressive pyoderma gangrenosum with pulse steroids and chlorambucil. J Am Acad Dermatol 27: 635-36, 1992.
64. Reynoso-von Drateln C, Perla-Navarro AV, Gamez-Nava JI, Gonzalez-Lopez L, Galvan-Villegas F, Ramos-Remus C. Intravenous cyclophosphamide pulses in pyoderma gangrenosum: An open trial. J Rheumatol 24: 689-93, 1997.
65. Samlaska CP, Smith RA, Myers JB, Bottini AG, Person DA. Pyoderma gangrenosum and cranial osteolysis: Case report and review of the paediatric literature. Br J Dermatol 133: 972-77, 1995.
66. Schlesinger IH, Farber GA. Cutaneous ulceration resembling pyoderma gangrenosum in the primary antiphospholipid syndrome: A report of two additional cases and review of the literature. J LA State Med Soc 147: 357-61, 1995.
67. Soria C, Allegue F, Martin M, Ledo A. Treatment of pyoderma gangrenosum with cyclosporine A. Clin Exp Dermatol 20: 293-94, 1989.
68. Suchniak JM, Warren KJ, Crosby DL, Fairley JA. Pyoderma gangrenosum of the skin, lungs, spleen and kidney [poster presentation]. American Academy of Dermatology. New Orleans, Louisiana, March 1999.
69. Teitel AD. Treatment of pyoderma gangrenosum with methotrexate. Cutis 57: 326-28, 1996.
70. Thiers, BH. Pyoderma gangrenosum. In: Arndt KA, LeBoit PE, Robinson JK, Wintroub BU, eds. Cutaneous medicine and surgery. Philadelphia: WB Saunders, 1996.
71. Tjandra JJ, Hughes LE. Parastomal pyoderma gangrenosum in inflammatory bowel disease. Dis Colon Rectum 37: 938-42, 1994.
72. Urano S, Kodama K, Nogura K. Pyoderma gangrenosum with systemic involvement. J Dermatol 22: 515-19, 1995.
73. Utrecht J. Dapsone and sulfapyridine. Clin Dermatol 7: 111-20, 1989.
74. Vignon-Pennamen MD, Wallach D. Neutrophilic disease: A review of extracutaneous manifestations. Eur J Dermatol 5: 449-55, 1995.
75. Vignon-Pennamen MD, Zelinsky-Gurung A, Janssen F, Frija J, Wallach D. Pyoderma gangrenosum with pulmonary involvement. 125:1239-42, 1989.
76. Von den Driesch P. Pyoderma gangrenosum: A report of 44 cases with follow-up. Br J Dermatol 137: 1000-5, 1997.
77. Wollheim FA. Acute and long-term complications of corticosteroid pulse therapy. Scand J Rheumatol 54(Suppl): 27-32, 1984.
78. Zonana-Nacach A, Jimenez-Balderas FJ, Martinez-Osuna P, Mintz G. Intravenous cyclophosphamide pulses in the treatment of pyoderma gangrenosum associated with rheumatoid arthritis: Report of 2 cases and review of the literature. J Rheumatol 21: 1352-56, 1994.